triazoles has been researched along with galactose in 70 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (2.86) | 18.7374 |
| 1990's | 2 (2.86) | 18.2507 |
| 2000's | 14 (20.00) | 29.6817 |
| 2010's | 49 (70.00) | 24.3611 |
| 2020's | 3 (4.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hart, DA; Kindel, PK | 1 |
| Brinkman, K; Kremer, HP; Kullberg, BJ; Meis, JF; Verweij, PE | 1 |
| Bretagne, S; Curfs, JH; Meis, JF; Verweij, PE; Weemaes, CM | 1 |
| Avila, N; Bacher, J; Candelario, M; Field-Ridley, A; Groll, AH; Petraitiene, R; Petraitis, V; Piscitelli, S; Sein, T; Walsh, TJ | 1 |
| Armstrong, D; Avila, NA; Bacher, J; Groll, AH; Hemmings, M; Lyman, CA; Mickiene, D; Peter, J; Petraitiene, R; Petraitis, V; Roussillon, K; Walsh, TJ | 1 |
| Bewley, JD; da Silva, EA; Hilhorst, HW; Nijsse, J; Toorop, PE | 1 |
| Blijlevens, NM; Donnelly, JP; Klont, RR; van der Velden, WJ; Verweij, PE | 1 |
| Leffler, H; Nilsson, UJ; Skogman, F; Tejler, J | 1 |
| Cantón, E; Chirivella, M; Crespo, M; Frasquet, J; Gobernado, M; Ortiz, R; Osseyran, F; Pemán, J; Pérez-Bellés, C; Quesada, A | 1 |
| Kohno, S; Kurashima, A; Maesaki, S; Niki, Y; Ogawa, K | 1 |
| Bocanegra, R; Fothergill, AW; Graybill, JR; Herrera, ML; Kinney, MC; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Vallor, AC; Wickes, BL | 1 |
| Maertens, J; Meersseman, W; Van Bleyenbergh, P | 1 |
| Avila, NA; Bacher, J; Cotton, MP; Francesconi, A; Hope, WW; Hughes, JE; Kasai, M; Meletiadis, J; Mickiene, D; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Stergiopoulou, T; Walsh, TJ | 1 |
| Bormans, G; Celen, S; Cleynhens, J; de Groot, T; Debyser, Z; Deroose, C; Gijsbers, R; Ibrahimi, A; Mortelmans, L; Verbruggen, A | 1 |
| Ben-Ami, R; Kontoyiannis, DP; Latgé, JP; Leventakos, K; Lewis, RE | 1 |
| Andrade, P; Campo, VL; Carvalho, I; Dedola, S; Field, RA; Guedes, PM; Hill, L; Nepogodiev, SA; Rejzek, M; Schenkman, S; Sesti-Costa, R; Silva, JS | 1 |
| Ahmad, S; Burhamah, MHA; Khan, ZU; Mokaddas, E | 1 |
| Clancy, CJ; Cline, C; Jantz, MA; Kulkarni, V; Leather, H; Nguyen, MH; Wheat, LJ; Wingard, JR | 1 |
| Chai, LY; Hsu, LY | 1 |
| Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC | 1 |
| Delaunay, J; Fraissinet, F; Gastinne, T; Gibas, CF; Le Pape, P; Miegeville, M; Morio, F; Sigler, L | 1 |
| Ko, WC; Lee, HC; Lo, HJ; Wu, CJ | 1 |
| Mugunthan, G; Ramakrishna, K; Ravindranathan Kartha, KP; Sriram, D; Yogeeswari, P | 1 |
| Falcone, M; Mancini, C; Morelli, A; Russo, A; Vena, A; Venditti, C; Venditti, M | 1 |
| Dawson, RM; Hughes, AB; Leaver, DJ; Polyzos, A; White, JM | 1 |
| Jones, B; Kirkpatrick, WR; Lappin, DF; McCulloch, E; Patterson, TF; Rajendran, R; Ramage, G; Shrief, R; Warn, P; Williams, C | 1 |
| Al-Saigh, R; Meletiadis, J; Roilides, E; Velegraki, A; Walsh, TJ; Zerva, L | 1 |
| Andrés, R; Elías, T; Fernandez de Orueta, L; Pintado, V | 1 |
| Al-Nakeeb, Z; Felton, TW; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Sudan, A; Warn, PA | 1 |
| Baghaei, P; Droudinia, A; Javanmard, P; Mansouri, D; Marjani, M; Najafizadeh, K; Sarrafzadeh, SA; Soraghi, A; Tabarsi, P; Zandian, P | 1 |
| Al-Nakeeb, Z; Arendrup, MC; Cuenca-Estrella, M; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Lass-Flörl, C; Majithiya, JB; Warn, PA | 1 |
| Caira, M; Cuenca-Estrella, M; Pagano, L | 1 |
| Campo, S; De Santis, R; Lo Giudice, P; Salvatori, G | 1 |
| Bojtarova, E; Cetkovsky, P; Drgona, L; Foralova, R; Forsterova, K; Guman, T; Haber, J; Kandrnal, V; Kocmanova, I; Kouba, M; Mallatova, N; Masarova, L; Mayer, J; Mudry, P; Muzik, J; Racil, Z; Sejnova, D; Tothova, E; Vydra, J; Weinbergerova, B; Ziakova, B | 1 |
| Atalay, MA; Koç, N; Sav, H; Unal, E | 1 |
| Calvo, E; Fothergill, AW; Guarro, J; Pastor, FJ; Salas, V; Sutton, DA | 1 |
| Calvo, E; Fothergill, AW; Guarro, J; Mayayo, E; Pastor, FJ; Rinaldi, MG; Salas, V; Sutton, DA | 1 |
| Li, R; Mu, X; Yu, J | 1 |
| Hino, M; Iino, M; Kanamaru, A; Koh, H; Masaoka, T; Ohta, K; Ohyashiki, K; Tamura, K; Tanimoto, M; Urabe, A; Urase, F; Usui, N; Yamaguchi, M; Yamanouchi, J; Yoshida, M | 1 |
| Clements, RM; Estrada, L; Jon, CK; Mosquera, RA | 1 |
| Chen, F; Shi, Y; Su, X; Sun, WK; Xu, XY; Zhang, M | 1 |
| Chai, LY; Earnest, A; Herbrecht, R; Johnson, EM; Kullberg, BJ; Netea, MG; Schlamm, HT; Teerenstra, S; Troke, PF; Vonk, AG | 1 |
| Abram, U; Apostolova, I; Barandov, A; Brenner, W; Buchert, R; Grünstein, D; Roger, M; Seeberger, PH | 1 |
| Arnan, M; Ayats, J; Cuenca-Estrella, M; Cuesta, I; Duarte, RF; Fernández de Sevilla, A; Gudiol, C; Patiño, B; Sánchez-Ortega, I | 1 |
| Bangard, C; Cornely, OA; Frank, K; Grönke, S; Hamprecht, A; Hekmat, K; Liss, B; Maintz, D; Markiefka, B; Michels, G; Vehreschild, JJ; Vehreschild, MJ; Wisplinghoff, H | 1 |
| Burley, GA; Clark, AW; Dondi, R; Graham, D; Kashmery, HA; Mabbott, S; Thompson, DG | 1 |
| Maertens, J; Miceli, MH | 1 |
| Box, H; Felton, TW; Goodwin, J; Hope, WW; Johnson, A; Livermore, J; McEntee, L; Whalley, S | 1 |
| Buitrago, MJ; Cendejas-Bueno, E; Forastiero, A; Gavaldà, J; Gomez-Lopez, A; Mellado, E; Ruiz, I | 1 |
| Hope, WW; Katragkou, A; Kovanda, LL; Moradi, PW; Petraitiene, R; Petraitis, V; Strauss, GE; Walsh, TJ | 1 |
| Bonate, P; Desai, A; Hope, WW; Kovanda, LL; Petraitiene, R; Petraitis, V; Walsh, TJ | 1 |
| Arnan, M; Ayats, J; Cuenca-Estrella, M; Duarte, RF; Patiño, B; Sánchez-Ortega, I; Sureda, A | 1 |
| Bassetti, M; Bouza, E | 1 |
| Hope, WW; Kolamunnage-Dona, R; Kovanda, LL; Lee, M; Maertens, J; Neely, M | 1 |
| Berking, S; Doedens, D; Fiegl, M; Horns, H; Ostermann, H; Rieger, CT | 1 |
| Hope, WW; Hussain, K; Kovanda, LL; Maung, BBW; McCarthy, MW; Petraitiene, R; Petraitis, V; Sekhon, NK; Shaikh, N; Walsh, TJ; Zaw, MH | 1 |
| Andrade, P; Campo, VL; Carvalho, I; Dias-Baruffi, M; Doti, N; Foca, G; Junqueira, GG; Marchiori, MF; Oliveira Bortot, L; Riul, TB; Ruvo, M | 1 |
| Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A | 1 |
| Akca, H; Alvur, O; Baygu, Y; Gok, Y; Kabay, N; Tokgun, O | 1 |
| Aslamkhan, AG; Gonzalez, R; Imredy, J; Kaczor, A; Kuhls, M; Lebron, J; Liaw, A; Liu, L; Mitra, K; Pearson, K; Ruth, M; Sistare, FD; Vu, H; Wei, C; Xu, Q; Yu, Y | 1 |
| Alanio, A; Bretagne, S; Chowdhary, A; Colley, T; Daly, L; Ito, K; Kimura, G; Kizawa, Y; Meis, JF; Nakaoki, T; Nishimoto, Y; Rapeport, G; Sharma, C; Strong, P | 1 |
| Alkhazraji, S; Alqarihi, A; Gebremariam, T; Gu, Y; Ibrahim, AS; Shaw, KJ; Singh, S | 1 |
| Böll, B; Böttiger, BW; Cornely, OA; Dusse, F; Eichenauer, DA; Fuchs, F; Hallek, M; Jung, N; Klein, F; Kochanek, M; Koehler, P; Persigehl, T; Rybniker, J; Shimabukuro-Vornhagen, A | 1 |
| Bellanger, AP; Berceanu, A; Bichard, D; Deconinck, E; Gbaguidi-Haore, H; Millon, L; Monnot, T; Montange, D; Scherer, E; Tatoyan, N | 1 |
| Nielsen, C; Pedersen, EB; Walczak, K | 1 |
| Dworkin, JP; Miller, SL | 1 |
| ELKHADEM, H | 1 |
| Asami, T; Chen, Z; Huang, LF; Mao, WH; Shi, K; Wu, JX; Xia, XJ; Yu, JQ; Zhou, YH | 1 |
| Deepthi, SB; Giribabu, L; Kumar, CG; Sujitha, P; Trivedi, R | 1 |
8 review(s) available for triazoles and galactose
| Article | Year |
|---|---|
[Native valve Aspergillus fumigatus endocarditis with blood culture positive and negative for galactomannan antigen. Case report and literature review].
Topics: Amaurosis Fugax; Aneurysm, Infected; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Biomarkers; Caspofungin; Combined Modality Therapy; Echinocandins; Endocarditis; False Negative Reactions; Fatal Outcome; Fungemia; Galactose; Heart Valve Prosthesis Implantation; Humans; Infarction; Kidney; Lipopeptides; Male; Mannans; Mesenteric Arteries; Mesenteric Vascular Occlusion; Middle Aged; Mitral Valve; Peptides, Cyclic; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Renal Artery; Triazoles; Voriconazole | 2007 |
New therapies for fungal pneumonia.
Topics: Amphotericin B; Antifungal Agents; Fungi; Galactose; Humans; Mannans; Mycoses; Pneumonia; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Triazoles; Voriconazole | 2009 |
Recent advances in invasive pulmonary aspergillosis.
Topics: Antifungal Agents; Biomarkers; Galactose; Humans; Invasive Pulmonary Aspergillosis; Lectins, C-Type; Mannans; Membrane Proteins; Nerve Tissue Proteins; Polymorphism, Genetic; Pyrimidines; Toll-Like Receptor 4; Triazoles; Voriconazole | 2011 |
Our 2015 approach to invasive pulmonary aspergillosis.
Topics: Antifungal Agents; Aspergillus; Bronchoalveolar Lavage Fluid; Chemoprevention; Fever of Unknown Origin; France; Galactose; Hospitals, University; Humans; Invasive Pulmonary Aspergillosis; Mannans; Microbial Sensitivity Tests; Radiography, Thoracic; Tomography, X-Ray Computed; Triazoles | 2015 |
Role of Non-Culture-Based Tests, with an Emphasis on Galactomannan Testing for the Diagnosis of Invasive Aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Bronchoalveolar Lavage Fluid; Galactose; Humans; Mannans; Proteoglycans; Triazoles; Voriconazole | 2015 |
Invasive mould infections in the ICU setting: complexities and solutions.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Critical Illness; Galactose; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Lung Diseases, Fungal; Mannans; Mucor; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory System; Triazoles; Voriconazole | 2017 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
CHEMISTRY OF OSOTRIAZOLES.
Topics: Carbohydrates; Chemical Phenomena; Chemistry; Chemistry Techniques, Analytical; Hexoses; Research; Sweetening Agents; Triazoles | 1963 |
6 trial(s) available for triazoles and galactose
| Article | Year |
|---|---|
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antigens, Fungal; Febrile Neutropenia; Female; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2013 |
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Biomarkers; Female; Fungal Polysaccharides; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints.
Topics: Animals; Antifungal Agents; Aspergillus; Disease Models, Animal; Drug Monitoring; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Microbial Sensitivity Tests; Models, Theoretical; Monte Carlo Method; Nitriles; Pyridines; Rabbits; Triazoles | 2016 |
Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response.
Topics: Adult; Aged; Biomarkers; Drug Monitoring; Female; Galactose; Humans; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Logistic Models; Male; Mannans; Middle Aged; Nitriles; Proportional Hazards Models; Pyridines; Survival Analysis; Treatment Outcome; Triazoles | 2017 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
57 other study(ies) available for triazoles and galactose
| Article | Year |
|---|---|
A novel reaction involved in the degradation of apiogalacturonans from Lemna minor and the isolation of apibiose as a product.
Topics: Carbon Isotopes; Cell Wall; Cellulose; Chromatography; Chromatography, Paper; Deuterium; Formaldehyde; Galactose; Hydrogen-Ion Concentration; Methods; Models, Structural; Oligosaccharides; Oxides; Pentoses; Periodic Acid; Plants; Polysaccharides; Temperature; Time Factors; Triazoles; Uronic Acids | 1970 |
Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management.
Topics: Aged; Amphotericin B; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; DNA, Fungal; Drug Resistance, Microbial; Female; Galactose; Humans; Mannans; Meningitis, Fungal; Mycology; Polymerase Chain Reaction; Pyrimidines; Time Factors; Triazoles; Voriconazole | 1999 |
Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biopsy, Needle; Child, Preschool; Diagnostic Errors; DNA, Fungal; Galactose; Granulomatous Disease, Chronic; Humans; Itraconazole; Lung Abscess; Lung Diseases, Fungal; Male; Mannans; Pyrimidines; Triazoles; Voriconazole | 2000 |
Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Galactose; Itraconazole; Lung Diseases, Fungal; Mannans; Neutropenia; Rabbits; Treatment Outcome; Triazoles | 2001 |
Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Dose-Response Relationship, Drug; Female; Galactose; Half-Life; Image Processing, Computer-Assisted; Immunosuppressive Agents; Injections, Intravenous; Lung; Mannans; Microbial Sensitivity Tests; Neutropenia; Rabbits; Survival Analysis; Tetrazolium Salts; Thiazoles; Tomography, X-Ray Computed; Triazoles | 2004 |
Exogenous gibberellins inhibit coffee (Coffea arabica cv. Rubi) seed germination and cause cell death in the embryo.
Topics: beta-Mannosidase; Cell Death; Coffea; Dose-Response Relationship, Drug; Fructose; Galactose; Germination; Gibberellins; Light; Mannose; Mannosidases; Seeds; Time Factors; Triazoles; Water | 2005 |
Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Galactose; Graft vs Host Disease; Humans; Liver Diseases; Lymphoproliferative Disorders; Mannans; Middle Aged; Pyrimidines; Rituximab; Splenic Diseases; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Synthesis of galactose-mimicking 1H-(1,2,3-triazol-1-yl)-mannosides as selective galectin-3 and 9N inhibitors.
Topics: Carbohydrate Conformation; Galactose; Galectin 3; Galectins; Hydrogenation; Indicators and Reagents; Mannosides; Models, Molecular; Triazoles | 2007 |
[Diagnosis and treatment of pulmonary aspergillosis. Role of voriconazole (discussion)].
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Biomarkers; Clinical Trials as Topic; Galactose; Humans; Immunoglobulin E; Lung Diseases, Fungal; Lung Diseases, Interstitial; Mannans; Practice Guidelines as Topic; Pyrimidines; Serologic Tests; Triazoles; Voriconazole | 2007 |
Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Base Sequence; Colony Count, Microbial; Disease Models, Animal; DNA Primers; DNA, Fungal; Galactose; Guinea Pigs; Humans; Immunoenzyme Techniques; Lung; Lung Diseases, Fungal; Male; Mannans; Mycology; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole | 2008 |
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.
Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Galactose; Humans; Mannans; Pulmonary Aspergillosis; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2009 |
Synthesis and biological evaluation of (11)C-labeled beta-galactosyl triazoles as potential PET tracers for in vivo LacZ reporter gene imaging.
Topics: Animals; beta-Galactosidase; Carbon Radioisotopes; Cell Line; Cell Membrane Permeability; Galactose; Gene Expression; Genes, Reporter; Humans; Kidney; Lac Operon; Male; Mice; Positron-Emission Tomography; Radioisotopes; Triazoles | 2009 |
Cutaneous model of invasive aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Catalase; Cyclophosphamide; Dermatomycoses; Disease Models, Animal; Female; Galactose; Hyphae; Immunocompromised Host; Immunosuppressive Agents; Mannans; Mice; Mice, Inbred BALB C; Mice, Nude; Mutagenesis; Skin; Spores; Triazoles; Virulence; Virulence Factors | 2010 |
'Click chemistry' synthesis of a library of 1,2,3-triazole-substituted galactose derivatives and their evaluation against Trypanosoma cruzi and its cell surface trans-sialidase.
Topics: Animals; Azides; Cell Line; Cell Survival; Chromatography, Thin Layer; Fluorometry; Galactose; Indicators and Reagents; Magnetic Resonance Spectroscopy; Membrane Proteins; Mice; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Neuraminidase; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Spleen; Structure-Activity Relationship; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1->3)-beta-D-glucan detection in serum samples as an adjunct to diagnosis.
Topics: Antifungal Agents; beta-Glucans; Child; Galactose; Humans; Lung Diseases, Fungal; Male; Mannans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteoglycans; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Biomarkers; Biopsy; Bronchoalveolar Lavage Fluid; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Postoperative Complications; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Triazoles; Voriconazole | 2011 |
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay.
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Base Sequence; Cross Reactions; Diagnosis, Differential; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Molecular Sequence Data; Mycoses; Neutropenia; Pyrimidines; Sensitivity and Specificity; Sordariales; Spores, Fungal; Triazoles; Voriconazole | 2011 |
Resolution of galactomannan antigenemia in a patient receiving oral voriconazole for chronic necrotizing pulmonary aspergillosis.
Topics: Antifungal Agents; Antigens, Fungal; Drug Monitoring; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2011 |
Synthesis and screening of galactose-linked nitroimidazoles and triazoles against Mycobacterium tuberculosis.
Topics: Galactose; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Triazoles | 2011 |
Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Comorbidity; Early Diagnosis; Female; Galactose; Hospital Units; Hospitals, University; Humans; Invasive Pulmonary Aspergillosis; Italy; Leukocyte Count; Male; Mannans; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2011 |
Synthesis of 1,2,3-triazole linked galactopyranosides and evaluation of cholera toxin inhibition.
Topics: Cholera Toxin; Galactose; Molecular Structure; Stereoisomerism; Triazoles | 2011 |
Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Biomarkers; Caspofungin; Disease Models, Animal; DNA, Fungal; Early Diagnosis; Echinocandins; Galactose; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Lipopeptides; Mannans; Microbiological Techniques; Mycological Typing Techniques; Predictive Value of Tests; Rats; Real-Time Polymerase Chain Reaction; Time Factors; Triazoles | 2012 |
Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Diffusion Chambers, Culture; Echinocandins; Galactose; Humans; Lipopeptides; Mannans; Microbial Sensitivity Tests; Pulsatile Flow; Pyrimidines; Species Specificity; Spores, Fungal; Triazoles; Voriconazole | 2012 |
[Vertebral aspergillosis in a cirrhotic patient: an uncommon cause of spondylitis].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biomarkers; Cross Infection; Fatal Outcome; Galactose; Haemophilus influenzae; Hepatitis C, Chronic; Humans; Immunocompromised Host; Liver Cirrhosis; Low Back Pain; Lumbar Vertebrae; Male; Mannans; Middle Aged; Multiple Organ Failure; Opportunistic Infections; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Spondylitis; Triazoles; Voriconazole | 2012 |
Pharmacodynamics of itraconazole against Aspergillus fumigatus in an in vitro model of the human alveolus: perspectives on the treatment of triazole-resistant infection and utility of airway administration.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cells, Cultured; Drug Administration Routes; Drug Resistance, Fungal; Flucytosine; Galactose; Humans; Itraconazole; Lung Diseases, Fungal; Mannans; Microbial Sensitivity Tests; Pulmonary Alveoli; Triazoles | 2012 |
Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients.
Topics: Adult; Antifungal Agents; Biomarkers; Bronchoalveolar Lavage Fluid; Caspofungin; Drug Therapy, Combination; Echinocandins; Galactose; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Mannans; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Transplantation; Triazoles; Voriconazole | 2012 |
Pharmacodynamics of voriconazole in a dynamic in vitro model of invasive pulmonary aspergillosis: implications for in vitro susceptibility breakpoints.
Topics: Antifungal Agents; Aspergillus fumigatus; Bioreactors; Cell Culture Techniques; Cells, Cultured; Chromatography, High Pressure Liquid; Computer Simulation; Decision Support Techniques; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Fungal; Endothelial Cells; Epithelial Cells; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Microbial Sensitivity Tests; Models, Biological; Pulmonary Artery; Pyrimidines; Respiratory Mucosa; Triazoles; Voriconazole | 2012 |
The management of febrile neutropenia in the posaconazole era: a new challenge?
Topics: Antifungal Agents; Antineoplastic Agents; Fever; Fungi; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mannans; Mycoses; Neutropenia; Polymerase Chain Reaction; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles | 2012 |
Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis.
Topics: Animals; Antifungal Agents; Body Burden; C-Reactive Protein; Colony Count, Microbial; Cortisone; Drug Combinations; Galactose; Immunosuppressive Agents; Kaplan-Meier Estimate; Lung; Mannans; Organ Size; Pulmonary Aspergillosis; Pyrimidines; Rats; Respiratory Function Tests; Serum Amyloid P-Component; Survival; Triazoles; Voriconazole | 2012 |
Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage Fluid; Child; Child, Preschool; Czech Republic; Databases, Factual; Echinocandins; Female; Galactose; Humans; Leukemia; Lung Diseases, Fungal; Male; Mannans; Middle Aged; Neutrophils; Pyrimidines; Retrospective Studies; Slovakia; Triazoles; Voriconazole; Young Adult | 2013 |
[The importance of bronchoalveolar lavage sample for galactomannan, 1,3-ß-d-glucan and PCR tests].
Topics: Antifungal Agents; beta-Glucans; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; Cystic Fibrosis; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lymphoma, Large B-Cell, Diffuse; Male; Mannans; Pyrimidines; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Evaluation of the in vitro activity of voriconazole as predictive of in vivo outcome in a murine Aspergillus fumigatus infection model.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Drug Resistance, Fungal; Galactose; Immunocompromised Host; Kidney; Male; Mannans; Mice; Microbial Sensitivity Tests; Predictive Value of Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
MIC values of voriconazole are predictive of treatment results in murine infections by Aspergillus terreus species complex.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Galactose; Male; Mannans; Mice; Microbial Sensitivity Tests; Prognosis; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2013 |
Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin.
Topics: Aged; Antifungal Agents; DNA, Fungal; Echinocandins; Emericella; Exudates and Transudates; Galactose; Glucocorticoids; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Microscopy; Molecular Sequence Data; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis.
Topics: Antifungal Agents; beta-Glucans; Biomarkers; Bronchoalveolar Lavage; Child; Cystic Fibrosis; Early Diagnosis; Fatal Outcome; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Pyrimidines; Triazoles; Voriconazole | 2013 |
Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species.
Topics: Animals; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Caspofungin; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Galactose; Humans; Lipopeptides; Male; Mannans; Microbial Sensitivity Tests; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Triazoles; Voriconazole | 2014 |
A new bifunctional chelator enables facile biocoupling and radiolabeling as the basis for a bioconjugation kit.
Topics: Animals; Chelating Agents; Crystallography, X-Ray; Galactose; Glycoconjugates; Isotope Labeling; Mice; Mice, Inbred BALB C; Molecular Conformation; Organotechnetium Compounds; Solvents; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Triazoles | 2014 |
Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Galactose; Humans; Mannans; Triazoles | 2014 |
SERS enhancement of silver nanoparticles prepared by a template-directed triazole ligand strategy.
Topics: Coloring Agents; Galactose; Ligands; Metal Nanoparticles; Nanotechnology; Rosaniline Dyes; Silver; Spectrum Analysis, Raman; Triazoles | 2015 |
Pharmacodynamics of Isavuconazole in a Dynamic In Vitro Model of Invasive Pulmonary Aspergillosis.
Topics: Antifungal Agents; Area Under Curve; Aspergillus fumigatus; Bioreactors; Diffusion Chambers, Culture; Drug Resistance, Fungal; Galactose; Humans; Mannans; Microbial Sensitivity Tests; Models, Biological; Models, Statistical; Nitriles; Pulmonary Alveoli; Pyridines; Triazoles | 2016 |
Galactomannan enzyme immunoassay and quantitative Real Time PCR as tools to evaluate the exposure and response in a rat model of aspergillosis after posaconazole prophylaxis.
Topics: Animals; Antifungal Agents; Biomarkers; Galactose; Immunoenzyme Techniques; Mannans; Pulmonary Aspergillosis; Rats; Real-Time Polymerase Chain Reaction; Triazoles | 2016 |
Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Female; Galactose; Invasive Pulmonary Aspergillosis; Mannans; Nitriles; Pyridines; Rabbits; Triazoles | 2016 |
Serum galactomannan surveillance may be safely withdrawn from antifungal management of hematology patients on effective antimold prophylaxis: a pilot single-center study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Fungi; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Mannans; Middle Aged; Mycoses; Prospective Studies; Triazoles | 2017 |
Antifungal prophylaxis in newly diagnosed AML patients-Adherence to guidelines and feasibility in a real life setting.
Topics: Adult; Aged; Antifungal Agents; Female; Fluconazole; Galactose; Guideline Adherence; Guidelines as Topic; Humans; Leukemia, Myeloid, Acute; Male; Mannans; Middle Aged; Mycoses; Pre-Exposure Prophylaxis; Retrospective Studies; Triazoles | 2017 |
Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.
Topics: Animals; Antifungal Agents; Combined Modality Therapy; Echinocandins; Female; Galactose; Glucans; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung; Mannans; Micafungin; Nitriles; Pyridines; Rabbits; Triazoles | 2017 |
Binding of triazole-linked galactosyl arylsulfonamides to galectin-3 affects Trypanosoma cruzi cell invasion.
Topics: Animals; Binding Sites; Blood Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Galactose; Galectin 3; Galectins; Glycoproteins; Haplorhini; Humans; Molecular Structure; Neuraminidase; Structure-Activity Relationship; Sulfonamides; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2017 |
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2018 |
The triazole linked galactose substituted dicyano compound can induce autophagy in NSCLC cell lines.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chloroquine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Galactose; Humans; Inhibitory Concentration 50; Lung Neoplasms; Microscopy, Electron, Transmission; Microtubule-Associated Proteins; Naphthyridines; Signal Transduction; TOR Serine-Threonine Kinases; Triazoles | 2019 |
Can Galactose Be Converted to Glucose in HepG2 Cells? Improving the
Topics: Amiodarone; Benzbromarone; Chemical and Drug Induced Liver Injury; Galactose; Glucose; Hep G2 Cells; Humans; Metabolomics; Mitochondria, Liver; Piperazines; Triazoles; Troglitazone; Tumor Cells, Cultured | 2019 |
Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus.
Topics: Animals; Antifungal Agents; Aspergillus; Colony Count, Microbial; Disease Models, Animal; France; Galactose; Humans; India; Lung; Mannans; Mice; Microbial Sensitivity Tests; Netherlands; Pulmonary Aspergillosis; Treatment Outcome; Triazoles | 2019 |
Galactomannan Is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biomarkers; Galactose; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lung; Male; Mannans; Mice; Microbial Sensitivity Tests; Triazoles | 2019 |
COVID-19 associated pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; Female; Galactose; Germany; Hemorrhage; Hospitals, Teaching; Humans; Intensive Care Units; Lung Diseases; Male; Mannans; Metapneumovirus; Middle Aged; Nitriles; Pandemics; Paramyxoviridae Infections; Pneumonia, Viral; Pulmonary Aspergillosis; Pyridines; Respiratory Distress Syndrome; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2020 |
Investigating the impact of posaconazole prophylaxis on systematic fungal screening using galactomannan antigen, Aspergillus fumigatus qPCR, and Mucorales qPCR.
Topics: Aspergillus fumigatus; Galactose; Humans; Invasive Fungal Infections; Mannans; Mass Screening; Mucorales; Real-Time Polymerase Chain Reaction; Retrospective Studies; Triazoles | 2021 |
Synthesis of 3'-azolyl-2',3'-dideoxyhexose nucleosides.
Topics: Antiviral Agents; Chromatography, High Pressure Liquid; Hexoses; HIV-1; Humans; Magnetic Resonance Spectroscopy; Nitroimidazoles; Nucleosides; Triazoles | 1998 |
A kinetic estimate of the free aldehyde content of aldoses.
Topics: Aldehydes; Circular Dichroism; Deoxy Sugars; Hexoses; Kinetics; Magnetic Resonance Spectroscopy; Molecular Structure; Pentoses; Structure-Activity Relationship; Triazoles | 2000 |
Brassinosteroids promote photosynthesis and growth by enhancing activation of Rubisco and expression of photosynthetic genes in Cucumis sativus.
Topics: Biomass; Blotting, Western; Brassinosteroids; Carbon Dioxide; Chlorophyll; Cholestanols; Cucumis sativus; Gene Expression Regulation, Plant; Hexoses; Kinetics; Photosynthesis; Plant Growth Regulators; Plant Leaves; Plant Proteins; Plant Roots; Reverse Transcriptase Polymerase Chain Reaction; Ribulose-Bisphosphate Carboxylase; Starch; Steroids, Heterocyclic; Sucrose; Triazoles | 2009 |
Effect of amide-triazole linkers on the electrochemical and biological properties of ferrocene-carbohydrate conjugates.
Topics: Amides; Anti-Infective Agents; Cell Line, Tumor; Cell Survival; Copper; Cycloaddition Reaction; Electrochemical Techniques; Ferrous Compounds; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Hexoses; Humans; MCF-7 Cells; Metallocenes; Pentoses; Stereoisomerism; Triazoles | 2013 |